US FDA's Decade In Review: From Biosimilars To Real-World Evidence

 
• By Brenda Sandburg
  
Evolutionary Decade at FDA
FDA actions on biosimilars, opioids and real-world evidence shaped the past decade
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership